![]() |
市场调查报告书
商品编码
1729499
日本胰岛素帮浦市场报告(按产品类型(胰岛素帮浦、胰岛素帮浦耗材及配件)、配销通路(医院药局、零售药局、线上销售、糖尿病诊所/中心等)和地区)2025 年至 2033 年Japan Insulin Pumps Market Report by Product Type (Insulin Pumps, Insulin Pumps Supplies and Accessories), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers, and Others), and Region 2025-2033 |
2024 年,日本胰岛素帮浦市场规模达 3.312 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 5.455 亿美元,2025-2033 年期间的成长率 (CAGR) 为 5.7%。糖尿病盛行率的不断上升、人们对胰岛素帮浦的偏好日益增加(而非传统的胰岛素注射)、技术的快速进步、老年人口的增加以及对研发 (R&D) 活动的重视程度的提高是推动市场发展的一些关键因素。
胰岛素帮浦是一种输送胰岛素到糖尿病患者的小型电子设备。它们通常佩戴在外部,要么在腰带上,要么放在口袋里,并通过称为输液器的细管连接到身体。帮浦持续输送胰岛素,模仿健康胰臟的功能。与传统的胰岛素注射相比,胰岛素帮浦提供了更灵活、更精确的胰岛素注射方式。它们既可以输送基础胰岛素(即持续释放少量胰岛素以控制两餐之间和睡眠期间的血糖水平),也可以输送推注胰岛素(即餐前註射较大剂量的胰岛素以弥补餐后血糖的升高)。
推动日本胰岛素帮浦市场发展的主要因素之一是糖尿病盛行率的不断上升。胰岛素帮浦在胰岛素输送方面提供了更大的便利性、灵活性和精确度,有助于改善血糖控制、减少低血糖发作并提高许多醣尿病患者的整体生活品质。同时,由于胰岛素帮浦提供的便利性和生活方式的益处,人们对胰岛素帮浦的偏好日益高于传统的胰岛素注射,这是另一个促进成长的因素。此外,日本政府实施各种倡议,为包括糖尿病管理在内的各种医疗治疗提供保障,为市场创造了积极的前景。除此之外,胰岛素帮浦技术的不断进步,例如整合连续血糖监测 (CGM) 系统的智慧型帮浦的开发,为患者提供更高的准确性、易用性和更好的血糖控制,为市场成长提供了相当大的推动力。此外,大众对胰岛素帮浦的好处和正确的糖尿病管理的认识不断提高,推动了市场的成长。此外,微创(MI)医疗技术的成长趋势与胰岛素帮浦的吸引力一致,胰岛素帮浦仅在输液器更换时插入针头,从而促进了市场的成长。其他因素,包括医疗保健行业的显着增长、消费者支出能力的提高、技术的快速进步、老年人口的增加、对研发活动的重视程度的提高以及对有效和便捷的糖尿病管理解决方案的需求不断增长,都为市场带来了有利可图的增长机会。
The Japan insulin pumps market size reached USD 331.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 545.5 Million by 2033, exhibiting a growth rate (CAGR) of 5.7% during 2025-2033. The increasing prevalence of diabetes, the rising preference for insulin pumps over traditional insulin injections, rapid technological advancements, increasing geriatric population, and enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.
Insulin pumps are small electronic devices that deliver insulin to individuals with diabetes. They are typically worn externally, either on a belt or in a pocket, and are connected to the body through a thin tube called an infusion set. The pump delivers insulin continuously, mimicking the function of a healthy pancreas. As compared to traditional insulin injections, insulin pumps offer a more flexible and precise way of administering insulin. They can deliver both basal insulin, which is a small amount of insulin continuously released to control blood sugar levels between meals and during sleep, as well as bolus insulin, which is a larger dose of insulin taken before meals to cover the rise in blood sugar after eating.
One of the major factors driving the Japan insulin pumps market is the increasing prevalence of diabetes. Insulin pumps offer greater convenience, flexibility, and precision in insulin delivery and help improve blood sugar control, reduce hypoglycemia (low blood sugar) episodes, and enhance the overall quality of life for many individuals with diabetes. In line with this, the rising preference for insulin pumps over traditional insulin injections due to the convenience and lifestyle benefits they offer is acting as another growth-inducing factor. Moreover, the implementation of various initiatives by the Japanese government to provide coverage for various medical treatments, including diabetes management, is creating a positive outlook for the market. Apart from this, continuous technological advancements in insulin pumps, such as the development of smart pumps with integrated continuous glucose monitoring (CGM) systems that offer improved accuracy, ease of use, and better glycemic control for patients is providing a considerable boost to the market growth. Furthermore, the increasing awareness about the benefits of insulin pumps and proper diabetes management among the masses is propelling the market growth. Additionally, the growing trend toward minimally invasive (MI) medical technologies aligns with the appeal of insulin pumps, which involve needle insertion only during the infusion set change is contributing to the market growth. Other factors, including significant growth in the healthcare industry, rising expenditure capacities of consumers, rapid technological advancements, increasing geriatric population, enhanced focus on research and development (R&D) activities, and growing demand for effective and convenient diabetes management solutions, are presenting remunerative growth opportunities for the market.